802 related articles for article (PubMed ID: 17197041)
1. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
[TBL] [Abstract][Full Text] [Related]
2. [Immune response in BALB/c mice immunized with BCG expressing HBV truncated C gene and preS1 gene].
Yin W; Lü X; Lei YF; Yang J; Sun MN; Ma Y; Lan HY; Wang AQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jan; 26(1):28-30. PubMed ID: 20056083
[TBL] [Abstract][Full Text] [Related]
3. [Immune response in mice induced by the fusion protein of HBcAg and HBV PreS1].
Chen XC; Zhou BP; Li MZ; Wang ZX; Wang HS; Zhang B; Tang W
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):184-5. PubMed ID: 12681075
[No Abstract] [Full Text] [Related]
4. [Immunological and virological efficacy against HBV chronic infection of the therapeutic vaccine composed of HBV core plus PreS1 in HBV transgenic mice].
Li MZ; Chen XC; Zhou BP; Le XH; Xu LM; Wang HS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):277-9. PubMed ID: 15340577
[TBL] [Abstract][Full Text] [Related]
5. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
Li X; Yang X; Li L; Liu H; Liu J
Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
7. Poliovirus recombinants expressing hepatitis B virus antigens elicited a humoral immune response in susceptible mice.
Yim TJ; Tang S; Andino R
Virology; 1996 Apr; 218(1):61-70. PubMed ID: 8615042
[TBL] [Abstract][Full Text] [Related]
8. [Boosting with HBV subunit particle vaccine enhance immune response of novel DNA vaccine consisting of S-PreS1 fusion gene in mice].
Chen H; Deng Y; Tan W; Wang W; Guan J; Wen B; Yin X; Ruan L
Sheng Wu Gong Cheng Xue Bao; 2011 Jan; 27(1):95-100. PubMed ID: 21553495
[TBL] [Abstract][Full Text] [Related]
9. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
Li L; Tian YJ; Shen H; Zhao XP; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
[TBL] [Abstract][Full Text] [Related]
10. Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection.
Chen X; Li M; Le X; Ma W; Zhou B
Vaccine; 2004 Jan; 22(3-4):439-46. PubMed ID: 14670326
[TBL] [Abstract][Full Text] [Related]
11. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
13. Enhancing the potency of HBV DNA vaccines using fusion genes of HBV-specific antigens and the N-terminal fragment of gp96.
Yan J; Liu X; Wang Y; Jiang X; Liu H; Wang M; Zhu X; Wu M; Tien P
J Gene Med; 2007 Feb; 9(2):107-21. PubMed ID: 17256801
[TBL] [Abstract][Full Text] [Related]
14. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095
[TBL] [Abstract][Full Text] [Related]
15. Behavior of a short preS1 epitope on the surface of hepatitis B core particles.
Borisova G; Borschukova O; Skrastina D; Dislers A; Ose V; Pumpens P; Grens E
Biol Chem; 1999 Mar; 380(3):315-24. PubMed ID: 10223334
[TBL] [Abstract][Full Text] [Related]
16. In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen.
Le Borgne S; Mancini M; Le Grand R; Schleef M; Dormont D; Tiollais P; Rivière Y; Michel ML
Virology; 1998 Jan; 240(2):304-15. PubMed ID: 9454704
[TBL] [Abstract][Full Text] [Related]
17. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of immune responses to the hepatitis B virus core protein through DNA vaccines with a DNA fragment encoding human IL-1beta 163-171 peptide.
Shao HJ; Chen L; Shen MS; Yu GF
Acta Virol; 2003; 47(4):217-21. PubMed ID: 15068376
[TBL] [Abstract][Full Text] [Related]
19. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
[TBL] [Abstract][Full Text] [Related]
20. Recombinant heat shock protein 65 carrying hepatitis B core antigen induces HBcAg-specific CTL response.
Yang BF; Zhao HL; Xue C; Xiong XH; Zhang W; Yao XQ; Liu ZM
Vaccine; 2007 May; 25(22):4478-86. PubMed ID: 17467856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]